Type I interferons have potent antiproliferatlve activity both in vitr
o and in vivo, and their tumor suppressor activity has been suggested.
A series of eukaryotic vectors containing a synthetic human consensus
type I interferon gene (IFN-con1) under the control of different prom
oters (cytomegalovirus early promoter, murine metallothionein promoter
and the Rous sarcoma virus LTR) were constructed and stably transfect
ed Into type I IFN-deficient myelogenous leukemic K562 cells. Constitu
tive expression of IFNcon1 reverted the malignant phenotype, as indica
ted by loss of tumorgenicity in nude mice. When stably transformed cel
ls were mixed with parental tumor cells, there was retardation of tumo
r growth. Constitutive expression of IFNcon1 reverted the malignant ph
enotype In vitro, as indicated by growth inhibition in culture, and re
duction in colony formation on soft agar. Furthermore, IFNcon1 gene ex
pression resulted in elevated erythroid differentiation, growth arrest
in S phase and induced apoptosis. Thus the presence of an active IFNc
on1 gene overcomes the oncogenic potential of K562 by coordinated modu
lation of cell proliferation, differentiation and programmed cell deat
h, and it acts as a tumor suppressor in vivo.